Bone Biologics Statistics
Total Valuation
Bone Biologics has a market cap or net worth of $3.82 million. The enterprise value is -$2.82 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, after market close.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Bone Biologics has 1.80 million shares outstanding. The number of shares has increased by 369.71% in one year.
Current Share Class | 1.80M |
Shares Outstanding | 1.80M |
Shares Change (YoY) | +369.71% |
Shares Change (QoQ) | +5.14% |
Owned by Insiders (%) | 0.04% |
Owned by Institutions (%) | 0.34% |
Float | 1.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.54 |
P/TBV Ratio | 0.58 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.24
Current Ratio | 17.24 |
Quick Ratio | 16.35 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -88.80% and return on invested capital (ROIC) is -56.45%.
Return on Equity (ROE) | -88.80% |
Return on Assets (ROA) | -52.63% |
Return on Invested Capital (ROIC) | -56.45% |
Return on Capital Employed (ROCE) | -65.08% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.72M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.86% in the last 52 weeks. The beta is 1.30, so Bone Biologics's price volatility has been higher than the market average.
Beta (5Y) | 1.30 |
52-Week Price Change | -68.86% |
50-Day Moving Average | 2.56 |
200-Day Moving Average | 4.73 |
Relative Strength Index (RSI) | 43.54 |
Average Volume (20 Days) | 6,210,534 |
Short Selling Information
The latest short interest is 7,784, so 0.43% of the outstanding shares have been sold short.
Short Interest | 7,784 |
Short Previous Month | 29,611 |
Short % of Shares Out | 0.43% |
Short % of Float | 0.47% |
Short Ratio (days to cover) | 0.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.29M |
Pretax Income | -5.12M |
Net Income | -7.43M |
EBITDA | n/a |
EBIT | -4.29M |
Earnings Per Share (EPS) | -$16.56 |
Full Income Statement Balance Sheet
The company has $6.64 million in cash and n/a in debt, giving a net cash position of $6.64 million or $3.70 per share.
Cash & Cash Equivalents | 6.64M |
Total Debt | n/a |
Net Cash | 6.64M |
Net Cash Per Share | $3.70 |
Equity (Book Value) | 6.60M |
Book Value Per Share | 3.91 |
Working Capital | 6.60M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -3.31M |
Capital Expenditures | n/a |
Free Cash Flow | -3.31M |
FCF Per Share | -$1.84 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |